Latest news
MEDIA RELEASE: Jan 20, 2023 08:55 AM
Genes that cause a rare childhood cancer revealed by Austral...
Australian researchers have created the first genetic map to identify important genes that cause sarcoma, one of the most common cancers in children.
MEDIA RELEASE: Mar 17, 2022 02:49 PM
$185 million investment to fast-track treatments for rare an...
The Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) will establish Australia as a medical manufacturing hub: building links from research through to the clinic; creating jobs; changing lives.
MEDIA RELEASE: Jun 23, 2021 07:12 PM
Precision medicine becomes more accessible for Australians w...
Garvan researchers launch new tool to inform targeted cancer treatment options.
MEDIA RELEASE: Mar 26, 2021 07:15 AM
World-first clinical trial targets immune molecule IL23 as p...
Sydney researchers are testing whether an existing medication could be repurposed to treat sarcoma.
MEDIA RELEASE: Feb 25, 2021 08:06 AM
Pancreatic cancer clinical trial program to target genome an...
Garvan and UNSW Sydney researchers will establish and lead an innovative pancreatic cancer clinical trial program, thanks to a $3.75 million grant from the Cancer Institute NSW.
MEDIA RELEASE: Jun 05, 2020 06:34 AM
Revealed: how cancer develops resistance to treatment
Garvan researchers reveal the tactic that cancer cells use to adapt and evade treatment.
May 22, 2020 09:13 AM
NHMRC Investigator Grants for Garvan researchers
Garvan researchers will receive a total of $4.8 million in Investigator Grant funding through the National Health and Medical Research Council (NHMRC), for projects beginning in 2021.
MEDIA RELEASE: Jan 23, 2020 09:01 PM
Researchers uncover the genomics of health
A DNA database of thousands of healthy older Australians is set to change how we determine which genes underpin disease.
MEDIA RELEASE: Sep 18, 2019 04:18 PM
Psoriasis drug target offers potential for osteosarcoma
Research reveals a new therapeutic target for the treatment of osteosarcoma.
Mar 11, 2018 10:00 AM
Major funding boost for prostate cancer in NSW
A new $3.75 million collaborative project aims to accelerate personalised approaches to prostate cancer treatment – and is part of a total package of $12 million awarded to cancer researchers at Garvan and across NSW.
Feb 02, 2018 05:30 PM
Funding needed for rare cancer treatment and research
Professor David Thomas, Head of Garvan’s Cancer Division and leader of the Australian Genomic Cancer Medicine Program, recently spoke about the state of funding for those with rare cancer.
Jan 22, 2018 09:00 PM
Key support for Garvan’s cancer research in 2018 and beyond
Garvan researchers are thrilled to be among the recipients of grants in recently announced funding schemes from the National Breast Cancer Foundation and Cancer Australia. The funding will provide crucial support for a n...
Dec 14, 2017 05:30 PM
Rare cancer patients in ACT gain local access to Garvan’s cl...
The Australian Genomic Cancer Medicine Program, led by Garvan’s Professor David Thomas, will be expanded to the Canberra Region Cancer Centre.
Nov 29, 2017 01:39 PM
Senate report a boost for research into low survival cancers...
Garvan welcomes the Senate Select Committee report into Funding for Research into Cancers with Low Survival Rates, tabled this week in Parliament.
MEDIA RELEASE: Aug 23, 2017 06:00 AM
Ground-breaking trial brings personalised treatments to thos...
Garvan's Genomic Cancer Medicine Program, launched today by The Hon. Brad Hazzard, uses genomic medicine to match therapies, prevention and screening methods with rare cancer patients based on their genetic information.
MEDIA RELEASE: Aug 04, 2017 01:00 AM
Top-to-toe MRI screen picks up early-stage cancers while sti...
A major study shows that whole-body MRI screening can identify previously undetected primary tumours throughout the body in people with high genetic risk of cancer.
MEDIA RELEASE: Aug 05, 2016 08:35 AM
Beyond ‘single-gene thinking’: Garvan researchers uncover co...
In a landmark multi-country study, Australian researchers have transformed our understanding of the genes that affect our risk of cancer.
MEDIA RELEASE: Nov 11, 2014 03:00 AM
Scientists solve mystery of ‘Frankenstein’ DNA
Scientists from Garvan, the Walter and Eliza Hall Institute of Medical Research and Peter MacCallum Cancer Centre have uncovered how the massive DNA molecules that appear in some tumours are formed like Frankenstein’s mo...
MEDIA RELEASE: Dec 19, 2013 12:00 AM
David Thomas appointed as new Director of The Kinghorn Cance...
Garvan is very pleased to announce the appointment of Professor David Thomas as the new Director of The Kinghorn Cancer Centre, as well as Head of Garvan’s Cancer Division, from June 2014. The Kinghorn Cancer Centre is a...